[1] Blériot C, Lecuit M. RIPK1, a key survival factor for hepatocytes. J Hepatol, 2007, 66: 1118-1119.
[2] Stanger BZ, Leder P, Lee TH, et al. RIP:a novel protein containing a death domain that interacts with Fas/Apo-1 (CD95) in yeast and causes cell death. Cell, 1995, 81: 513-523.
[3] Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature, 2015, 517: 311-320.
[4] Filliol A, Piquet-Pellorce C, Raguénès-Nicol C, et al. RIPK1 protects hepatocytes from Kupffer cells-mediated TNF-induced apoptosis in mouse models of PAMP-induced hepatitis. J Hepatol, 2017, 66: 1205-1213.
[5] Filliol A, Piquetpellorce C, Le Seyec J, et al. RIPK1 protects from TNF-α-mediated liver damage during hepatitis. Cell Death Disease, 2016, 7: e2462.
[6] Schneider AT, Gautheron J, Feoktistova M, et al. RIPK1 suppresses a TRAF2-dependent pathway to liver cancer. Cancer Cell, 2017, 31: 94-109.
[7] Dannappel M, Vlantis K, Kumari S, et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature, 2014, 513: 90-94.
[8] Rickard JA, O’Donnell JA, Evans JM, et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell, 2014, 157: 1175-1188. |
